Company: IMRX
Filing Date: 2025-11-12
Form Type: 10-Q
Source: 0001790340-25-000135
Chunk: 322

Company: Immuneering Corp
Filing Date: 2025-11-12
Form: 10-Q
Item: Part II, Item 1A
Chunk 322
---
 a contractual standard of materiality different from those generally applicable under securities laws, among other limitations. The representations and warranties were made for purposes of allocating contractual risk between the parties to the agreement and should not be relied upon as a disclosure of factual information relating to the Company, the investor(s) and/or the transactions described herein or therein.

101

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, duly authorized. 

IMMUNEERING CORPORATIONDate: November 12, 2025By:/s/ Benjamin J. ZeskindName:Benjamin J. Zeskind, Ph.D.Title:Co-Founder, President, Chief Executive Officer and Director (Principal Executive Officer)Date: November 12, 2025By:/s/ Mallory MoralesName:Mallory MoralesTitle:Chief Accounting Officer and Treasurer(Principal Financial Officer and Principal Accounting Officer)

102